Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Bausch Health Companies (BHC)

Bausch Health Companies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:BHC
DateTimeSourceHeadlineSymbolCompany
11/04/202416:17PR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - BHCTSX:BHCBausch Health Companies Inc
11/04/202416:17PR Newswire (Canada)Canadian Investment Regulatory Organization Trade Resumption - BHCTSX:BHCBausch Health Companies Inc
11/04/202416:08PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - BHCTSX:BHCBausch Health Companies Inc
11/04/202416:03PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - BHCTSX:BHCBausch Health Companies Inc
03/04/202417:08PR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - BHCTSX:BHCBausch Health Companies Inc
03/04/202417:05PR Newswire (Canada)Canadian Investment Regulatory Organization Trade Resumption - BHCTSX:BHCBausch Health Companies Inc
03/04/202417:04PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - BHCTSX:BHCBausch Health Companies Inc
03/04/202417:01PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - BHCTSX:BHCBausch Health Companies Inc
01/11/202314:44PR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - BHCTSX:BHCBausch Health Companies Inc
01/11/202314:43PR Newswire (Canada)Canadian Investment Regulatory Organization Trade Resumption - BHCTSX:BHCBausch Health Companies Inc
01/11/202314:43PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - BHCTSX:BHCBausch Health Companies Inc
01/11/202314:40PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - BHCTSX:BHCBausch Health Companies Inc
31/05/202313:00PR Newswire (US)OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum DiseaseTSX:BHCBausch Health Companies Inc
17/05/202318:34PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - BHCTSX:BHCBausch Health Companies Inc
17/05/202318:33PR Newswire (Canada)IIROC Trade Resumption - BHCTSX:BHCBausch Health Companies Inc
17/05/202318:18PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - BHCTSX:BHCBausch Health Companies Inc
17/05/202318:17PR Newswire (Canada)IIROC Trading Halt - BHCTSX:BHCBausch Health Companies Inc
17/05/202317:47PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - BHCTSX:BHCBausch Health Companies Inc
17/05/202317:46PR Newswire (Canada)IIROC Trade Resumption - BHCTSX:BHCBausch Health Companies Inc
17/05/202317:44PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - BHCTSX:BHCBausch Health Companies Inc
17/05/202317:43PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - BHCTSX:BHCBausch Health Companies Inc
17/05/202317:43PR Newswire (Canada)ttIIROC Trading Halt - BHCTSX:BHCBausch Health Companies Inc
17/05/202317:41PR Newswire (Canada)IIROC Trading Halt - BHCTSX:BHCBausch Health Companies Inc
03/05/202311:58PR Newswire (Canada)RYALTRIS®, a new combination prescription nasal spray for moderate to severe seasonal allergic rhinitis (SAR), now available across CanadaTSX:BHCBausch Health Companies Inc
03/05/202311:58PR Newswire (Canada)RYALTRIS(MD), une nouvelle association sous ordonnance en pulvérisateur nasal pour la rhinite allergique saisonnière (RAS) d'intensité modérée à grave, est maintenant disponible partout au CanadaTSX:BHCBausch Health Companies Inc
22/12/202211:59PR Newswire (Canada)First tazarotene lotion treatment for acne vulgaris, ARAZLO™ (tazarotene lotion, 0.045%), now available to patients through Quebec, Ontario, Alberta, Saskatchewan and federal NIHB public drug plansTSX:BHCBausch Health Companies Inc
22/12/202211:59PR Newswire (Canada)ARAZLOMC (lotion de tazarotène, 0,045 %), la première lotion à base de tazarotène indiquée pour le traitement de l'acné vulgaire, est maintenant offerte aux patients du Québec, de l'Ontario, de l'Alberta et de la Saskatchewan dans le cadre des régiTSX:BHCBausch Health Companies Inc
17/11/202218:08PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - BHCTSX:BHCBausch Health Companies Inc
17/11/202218:06PR Newswire (Canada)IIROC Trade Resumption - BHCTSX:BHCBausch Health Companies Inc
17/11/202218:04PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - BHCTSX:BHCBausch Health Companies Inc
 Showing the most relevant articles for your search:TSX:BHC

Your Recent History

Delayed Upgrade Clock